HB4003, the “Funding the Future of Oklahoma – TSET Modernization Act,” restructures the Tobacco Settlement Endowment Trust (TSET) system and creates a new grant program to carry forward some of TSET’s public health funding functions. The bill amends the statutes governing the trust’s purpose, board appointments, investment authority, and annual earnings determinations. It removes references to the Board of Directors in several places, expands and clarifies the duties of the Board of Investors, limits certain investments in venture capital to no more than 10% of trust value, and directs the board to distribute trust earnings under constitutional and statutory methodologies, including amounts needed to fully fund Oklahoma Higher Learning Access Act awards.
The bill also creates the TSET Legacy Effort Revolving Fund in the State Treasury, administered by the State Department of Health, to finance “Legacy Effort Grants.” Those grants are limited to private, nonprofit, and public entities that received TSET grant funding during calendar year 2025. The department must develop competitive grant processes, and the bill exempts these awards from the Oklahoma Central Purchasing Act. It also sets confidentiality rules for solicitations and applications until public release or award, after which the Oklahoma Open Records Act and Open Meeting Act apply, and it caps total grant awards at available fund balances.
In addition, HB4003 repeals several existing statutory sections related to the Board of Directors and its powers and budget, signaling a shift away from the prior board structure and toward a more centralized investment-and-grants framework. The bill is conditioned on voter approval of a separate state question, so it would not take effect unless that constitutional change is adopted.
The general sentiment reflected in the available voting history appears supportive but not unanimous. The bill advanced out of the House Rules Committee on a 9-3 vote and passed House third reading 62-31, indicating meaningful majority support with a notable minority of opposition. No committee transcript is available, so specific arguments are not recorded in the provided materials.
The main points of contention likely center on the governance changes to TSET, the transfer of grant administration to the Department of Health, the exemption from the Central Purchasing Act, and the confidentiality provisions for grant solicitations and applications. Supporters appear to favor modernization, continuity of funding, and clearer investment and grant procedures, while opponents may be concerned about reduced oversight, changes to existing board authority, and the concentration of discretion in the new grant process.
HB4003 would amend multiple sections of Title 62 governing the Tobacco Settlement Endowment Trust, eliminate statutory references to the Board of Directors in favor of a more limited Board of Investors role, and create a new revolving fund and grant program administered by the State Department of Health. It would also repeal existing provisions on the board’s powers and budget, change investment and earnings-determination rules, and affect entities that currently receive TSET-funded grants, especially those eligible for Legacy Effort Grants. The bill’s effective date is contingent on voter approval of a related constitutional state question.
The bill appears to have received generally favorable consideration in the House, but not without opposition. It cleared the House Rules Committee 9-3 and passed the House on third reading 62-31, suggesting broad support from a majority of members alongside a substantial minority that was unconvinced. Because no committee transcript is available, the record does not show detailed debate, but the vote margins indicate the measure was somewhat contentious rather than broadly unanimous.
Likely areas of disagreement include the restructuring of TSET governance, the removal of the Board of Directors’ statutory role, and the shift of grant administration to the State Department of Health. The exemption from the Oklahoma Central Purchasing Act and the temporary confidentiality of grant solicitations and applications may also raise transparency and procurement concerns. Supporters likely view these changes as modernization and continuity for public health funding, while critics may worry about reduced oversight, less competitive accountability, and the concentration of authority over grant awards.